Amundi Grifols Sa Transaction History
Amundi
- $253 Billion
- Q2 2024
A detailed history of Amundi transactions in Grifols Sa stock. As of the latest transaction made, Amundi holds 62,712 shares of GRFS stock, worth $560,018. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,712
Previous 105,791
40.72%
Holding current value
$560,018
Previous $706,000
44.05%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding GRFS
# of Institutions
147Shares Held
151MCall Options Held
2.38MPut Options Held
662K-
Capital World Investors Los Angeles, CA20.9MShares$187 Million0.02% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA18.6MShares$166 Million1.52% of portfolio
-
Permian Investment Partners, LP New York, NY14.1MShares$126 Million11.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny13.9MShares$124 Million0.04% of portfolio
-
Black Creek Investment Management Inc. Toronto, A612.3MShares$110 Million2.9% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $6.06B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...